The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer (Q27853340)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer |
scientific article |
Statements
1 reference
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer (English)
1 reference
Beatriz Bellosillo
Mariona Gelabert-Baldrich
Alba Dalmases
Israel Cañadas
Joana Vidal
Alejandro Martinez
Guillem Argilés
Klaus Koefoed
Laura Visa
Oriol Arpí
Ivan David Horak
Mar Iglesias
Christopher Stroh
Michael Kragh
Ana Rovira
Joan Albanell
1 July 2016
0 references
Identifiers
2 references
2 references